Nakanishi S*, Sato H*, Oikawa Y, Ikebukuro K, Shimada A. Shared Pathogenic Features Between Serotonin Receptor Antagonist-Associated Diabetic Ketosis and Ketosis-Prone Type 2 Diabetes: A Case Report. Cureus. 2025 Apr 23;17(4):e82833. (* equally contributed to this work.)
Oikawa Y, Haisa A, Satomura A, Shimada A. Update on slowly progressive type 1 diabetes. J Diabetes Investig. 2024 (In press).
Mitsui E*, Satomura A*, Oikawa Y, Haisa A, Shimada A. Mitochondrial DNA 3243 mutation may be associated with positivity of zinc transporter 8 autoantibody in cases of slowly progressive type 1 diabetes mellitus. Diabetol Int. 2024 Nov 21;16(1):188-193. (* equally contributed to this work.)
Ebisuno T, Tachibana M, Imagawa A, Kanatsuna N, Terasaki J, Abiru N, Awata T, Ikegami H, Oikawa Y, Osawa H, Katsuki T, Kawasaki E, Kozawa J, Kobayashi T, Shimada A, Takahashi K, Chujo D, Tsuchiya K, Nagasawa K, Fukui T, Yasuda K, Yasuda H, Kajio H, Hanafusa T. Analysis of thyroid autoantibodies and the risk of insulin depletion after the clinical onset of acute-onset type 1 diabetes in Japanese patients: the TIDE-J study. Diabetol Int. 2024 Oct 9;16(1):39-49.
Horii T, Masudo C, Takayanagi Y, Oikawa Y, Shimada A, Mihara K. Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data. J Diabetes Investig. 2024 Nov;15(11):1578-1584.
Horii T, Oikawa Y, Kidowaki K, Shimada A, Mihara K. Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan. J Diabetes Investig. 2024 Nov;15(11):1651-1662.
Ito D, Inoue I, Yanagisawa S, Inoue K, Saito D, Sumita T, Uchida Y, Inukai K, Shimada A. Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5-year observational follow-up of a randomized, 24-week, active-controlled trial: Effect of ipragliflozin in MASLD. J Diabetes Investig. 2024 Sep;15(9):1220-1230.
Meguro S, Sakane N, Hosoda K, Hirota Y, Itoh A, Kato K, Kodani N, Kuroda A, Matsuhisa M, Miura J, Shimada A, Tone A, Toyoda M, Murata T & The ISCHIA Study Group. Diurnal variation in the association between the scan frequency of isCGM and CGM metrics: post hoc analysis of the ISCHIA study. Diabetol Int. 2024 Aug 19;15(4):828-836.
Haisa A, Oikawa Y, Satomura A, Suzuki S, Nakanishi S, Fujisawa M, Morita H, Katsuki T, Shimada A. High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults. Diabetes Res Clin Pract. 2024 Jul 30;215:111799.
Matsuo K, Inoue I, Matsuda T, Arai T, Nakano S. Relative Increase in Production Ratio of Small Dense Low-Density Lipoprotein in Acute Coronary Syndrome with High Coronary Plaque Burden: An Ex-Vivo Analysis. Heart Vessels. 2025 Jan;40(1):26-35.
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM, probable) cases (English Version). Diabetol Int. 2024 Nov 12;16(1):1-6.
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM, probable) cases (English Version). J Diabetes Investig. 2025 Jan;16(1):163-168.
Kawasaki E, Awata T, Ikegami H, Imagawa A, Oikawa Y, Osawa H, Katsuki T, Kanatsuna N, Kawamura R, Kozawa J, Kodani N, Kobayashi T, Shimada A, Shimoda M, Takahashi K, Chujo D, Tsujimoto T, Tsuchiya K, Terakawa A, Terasaki J, Nagasawa K, Noso S, Fukui T, Horie I, Yasuda K, Yasuda H, Yanai H, Hanafusa T, Kajio H; Japanese Type 1 Diabetes Database Study (TIDE-J). Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes. J Diabetes Investig. 2024 July 1;15(7):835-842.
Takenaka Y, Kakinuma Y, Ikeda M, Inoue I. Shared Mechanisms in Pparγ1sv and Pparγ2 Expression in 3T3-L1 Cells: Studies on Epigenetic and Positive Feedback Regulation of Pparγ during Adipogenesis. PPAR Res. 2024 Jun 7;2024:5518933.
Yanagisawa S, Oikawa Y, Endo M, Inoue K, Nakajima R, Yasuda S, Sato M, Iwata N, Fujisawa H, Suzuki A, Sugimura Y, Isshiki M, Shimada A. A pregnant woman with excess vasopressinase-induced diabetes insipidus complicated by central diabetes insipidus like lymphocytic infundibulo-neurohypophysitis: a case report. Case Rep Endocrinol. 2024 Apr 13;2024:8687054.
ISCHIA Study Group; Murata T, Hirota Y, Hosoda K, Kato K, Kouyama K, Kouyama R, Kuroda A, Matoba Y, Matsuhisa M, Meguro S, Miura J, Nishimura K, Sakane N, Shimada A, Suzuki S, Tone A, Toyoda M. Predictors of the effectiveness of isCGM usage in adults with type 1 diabetes mellitus: post-hoc analysis of the ISCHIA study. Diabetol Int. 2024 Feb 15;15(3):400-405.
Mizutani G, Isshiki M, Shimizu E, Saito D, Shimada A. Pheochromocytoma With High Adrenocorticotropic Hormone Production Capacity Without Pigmentation and Cushingoid Symptoms: A Case Report With a Literature Review. Cureus. 2024 Feb 1;16(2):e53358.
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version). J Diabetes Investig. 2024 Feb;15(2):254-257.
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version). Diabetol Int. 2024 Jan 8;15(1):1-4.
Yamanouchi Y, Senbonmatsu T, Yamaguchi T, Inoue I, Goto S, Soma T, Maruyama Y, Adachi M, Shinozuka N, Muramatsu T. Medical Record Survey after Comprehensive Health Checkup Referral and Its Contribution to the Early Detection of Cancer. J Pers Med. 2024, 14:59.
Kawai S, Yamakage H, Kotani K, Noda M, Satoh-Asahara N, Hashimoto K. Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy. Endocr J. 2023 Dec 28;70(12):1175-1186.
Nishimura R, Shimada A, Abiru N, Matsuhisa M, Takahashi Y, Ikegami H. Association between glycemic control and patient-reported outcomes in adults with type 1 diabetes in Japan: the SAGE study subanalysis. Diabetol Int. 2023 Nov 22;15(2):212-222.
Toyoda M, Murata T, Hirota Y, Hosoda K, Kato K, Kouyama K, Kouyama R, Kuroda A, Matoba Y, Matsuhisa M, Meguro S, Miura J, Nishimura K, Shimada A, Suzuki S, Tone A, Sakane N; ISCHIA Study Group. Possible Relationship between the Deteriorated Accuracy of Intermittent-Scanning Continuous Glucose Monitoring Device and the Contact Dermatitis: Post-hoc analysis of the ISCHIA Study. Tokai J Exp Clin Med. 2023 Sep 20;48(3):83-90.
Takenaka Y, Inoue I, Hirasaki M, Ikeda M, Kakinuma Y. Temporal inhibition of the electron transport chain attenuates stress-induced cellular senescence by prolonged disturbance of proteostasis in human fibroblasts. FEBS J. 2023 Aug;290(15):3843-3857.
Horii T, Oikawa Y, Shimada A, Mihara K. Real‐world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium–glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score‐matched model analysis in Japan. J Diabetes Investig. 2023 Nov;14(11):1262-1267.
Bouchi R, Noda M, Hayashino Y, Goto A, Yamazaki K, Suzuki H, Furukawa TA, Izumi K, Kobayashi M; J-DOIT2 Study Group. Behavioral change stage might moderate the impact of multifaceted interventions on non-attendance from medical care among patients with type 2 diabetes: The Japan Diabetes Outcome Intervention Trial-2 Large-Scale Trial 007 (J-DOIT2-LT007). J Diabetes Investig. 2023 Jul;14(7):907-916.
Tamura Y, Kaga H, Abe Y, Yoshii H, Seino H, Hiyoshi T, Kuribayashi N, Inoue I, Watada H. Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study). Nutrients. 2023 Jun 24;15(13):2866.
Fukui T, Kobayashi T, Jimbo E, Aida K, Shimada A, Oikawa Y, Mori Y, Fujii T, Koyama R, Kobayashi K, Takeshita A, Yagihashi S. Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus. Sci Rep. 2023 Apr 28;13(1):6977.
Yasuda S, Suzuki S, Yanagisawa S, Morita H, Haisa A, Satomura A, Nakajima R, Oikawa Y, Inoue I, Shimada A. HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report. BMC Endocr Disord. 2023 Mar 7;23(1):54.
Kawasaki E, Shimada A, Imagawa A, Abiru N, Awata T, Oikawa Y, Osawa H, Kawabata Y, Kozawa J, Kobayashi T, Takahashi K, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kajio H, Hanafusa T, Ikegami H; Committee of type 1 diabetes, Japan Diabetes Society. Bivalent GAD autoantibody ELISA Improves clinical utility and risk prediction for adult autoimmune diabetes. J Diabetes Investig. 2023 Apr;14(4):570-581.
Yamanouchi Y, Inoue I, Goto S, Maruyama Y. Obesity, Atherosclerotic Risk Factors, and Metabolic Syndrome in Vascular Aging and Treatment in the Elderly. Health Evaluation and Promotion. 2023;50(4):403-411.